Literature DB >> 2297474

The natural history of amaurosis fugax with minor degrees of internal carotid artery stenosis.

S Torem1, M E Rossman, P A Schneider, S M Otis, R B Dilley, E F Bernstein.   

Abstract

The natural history of amaurosis fugax with hemodynamically insignificant degrees of internal carotid artery stenosis is uncertain. Seventy-three patients over age 40 who presented with amaurosis fugax without obvious cause and had ipsilateral stenoses of 50% or less with carotid duplex scanning were followed for a mean period of 35.5 months (range 3-110) without surgical intervention. At the initial vascular laboratory duplex evaluation, 35 patients had normal arteries (47.9%), 29 had minor (0-19%) stenoses of the ipsilateral internal carotid arteries (39.7%), and 11 had 20-50% stenosis (15.1%). Four patients with 0-19% stenosis and one patient with 20-50% stenosis experienced a subsequent stroke or permanent ipsilateral blindness. When analyzed by life-table format, stroke, blindness, and early death were more frequent in patients with minor degrees of stenosis than in those with normal arteries. Investigations in all patients with amaurosis fugax should be aimed at identifying whether the symptoms are explained by arteriosclerotic, systemic, collagen, cardiac, hematologic, or ophthalmologic disease. When no other etiology is found, and localized carotid bifurcation atherosclerosis of even modest degrees is identified, an atheroembolic etiology should be considered.

Entities:  

Mesh:

Year:  1990        PMID: 2297474     DOI: 10.1007/BF02042689

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Ultrasound morphology of carotid lesions in retinal ischaemia.

Authors:  C M O'Farrell; D E FitzGerald
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

2.  Prognostic value of carotid ultrasound lesion morphology in retinal ischaemia: result of a long term follow up.

Authors:  C M O'Farrell; D E FitzGerald
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.